|
DE4234225A1
|
|
Stable topical formulations with good active ingredient release capacity containing at least one lipophilized macrolide antibiotic
|
|
DE4212105A1
|
|
Nail polish for the treatment of onychomycoses
|
|
EP0369292A1
|
|
Diagnostic unit dose for the determination of urease
|
|
DE3908232A1
|
|
Use of verapamil for the treatment of sleep apnea
|
|
ES2002917A6
|
|
Topical pharmaceutical compsns.
|
|
IE861311L
|
|
Pharmaceutical preparations
|
|
DE3612305A1
|
|
LIQUID MEDICINE FOR THERAPY OF PSORIASIS BASED ON FILM-FORMING POLYMERS
|
|
DE3606265A1
|
|
POLYSACCHARID-BASED Wound Dressing As a Carrier Therapeutically Effective, Non-Immobilized Enzymes and with High Absorbency
|
|
DE3603859A1
|
|
WASHABLE TOPICAL PREPARATION FOR THERAPY OF PSORIASIS
|
|
DE3542773A1
|
|
SKIN-ACTIVE PHARMACA WITH LIPOSOMES AS AN ACTIVE SUBSTANCE
|
|
DE3517820A1
|
|
PHARMACEUTICAL PREPARATIONS WITH ANTI-HYPERTENSIVE AND CARDIOPROTECTIVE EFFECT
|
|
DE3417628A1
|
|
Composition for treating induced myopathies
|
|
DE3413569A1
|
|
PHARMACEUTICAL AGENT FOR PSORIASIS THERAPY
|
|
DE3412765A1
|
|
Triaminoarylpteridinverbindungen
|
|
DE3448490C2
|
|
Use of pteridine derivatives for the treatment of cardiac arrhythmias
|
|
DE3407695A1
|
|
PTERIDINE COMPOUNDS WITH PHARMACEUTICAL EFFECTIVENESS
|
|
DE3210138A1
|
|
ANTIMYCOTIC, THERAPEUTIC PREPARATIONS ON A CREAM AND OINTAGE BASIS
|
|
DE3203479A1
|
|
Process for the preparation of stabilised aqueous barium sulphate suspensions
|
|
DE3139089A1
|
|
Protein-based sheet-like structures as carriers of therapeutically active, non-immobilised enzymes
|
|
AU6587380A
|
|
2,4,7-triamino-pteridine derivative compositions
|
